Recombinant p27 KIP 1 Monoclonal Antibody
Product Sizes
50 ul
£246.00
AN301021L-50UL
100 ul
£346.00
AN301021L-100UL
About this Product
- SKU:
- AN301021L
- Additional Names:
- KIP;MEN;CDKN;Cyclin-Dependent Kinase Inhibitor p;P27KIP;p27 KIP;CDKN1B;CDKN4;KIP1;MEN1B;MEN4;P27KIP1;p27 KIP 1;Cyclin-Dependent Kinase Inhibitor 1B;Cyclin-Dependent Kinase Inhibitor p27;AA408329;AI843786;Cdki1b;CDKN 1B;CDKN 4;CDN1B;Cyclin Dependent Kinase Inhibitor 1B;Cyclin dependent kinase inhibitor p27;Cyclin-dependent kinase inhibitor 1B (p27;Cyclin-dependent kinase inhibitor p27 Kip1;KIP 1;Kip1);OTTHUMP00000195098;OTTHUMP00000195099;p27;p27 Kip1;P27-like cyclin-dependent kinase inhibitor;p27
- Application:
- ELISA, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, Western Blot
- Buffer:
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
- translate.label.attr.clone:
- B772
- Clonality:
- Monoclonal, Recombinant Monoclonal
- Concentration:
- 0.2 mg/ml
- Extra Details:
- This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).
- Host:
- Rabbit
- Immunogen:
- Recombinant Human p27 KIP 1 protein
- Isotype:
- IgG, kappa
- Purification:
- Protein A Purified
- Reactivities:
- Human, Mouse, Rat
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles.
- Supplier:
- Elabscience
- Type:
- Antibody: Recombinant Antibodies
- Manufacturer's Data Sheet:p-recombinant_p27_kip_1_monoclonal_antibody-an301021l
